VanEck Associates’s Enviva Inc. EVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-550
Closed -$4K 1440
2023
Q3
$4K Buy
550
+1
+0.2% +$10 ﹤0.01% 1384
2023
Q2
$6K Sell
549
-1,469
-73% -$21.4K ﹤0.01% 1378
2023
Q1
$58K Sell
2,018
-312
-13% -$12.7K ﹤0.01% 1300
2022
Q4
$123K Buy
+2,330
New +$133K ﹤0.01% 1217
2019
Q4
Sell
-44,286
Closed -$1.42M 1012
2019
Q3
$1.42M Buy
44,286
+2,228
+5% +$68.6K 0.01% 533
2019
Q2
$1.32M Buy
42,058
+865
+2% +$27.4K 0.01% 538
2019
Q1
$1.33M Buy
41,193
+41,143
+82,286% +$1.23M 0.01% 518
2018
Q4
$1K Buy
50
+1
+2% +$30 ﹤0.01% 831
2018
Q3
$2K Buy
+49
New +$1.5K ﹤0.01% 790
2018
Q1
Sell
-110,535
Closed -$3.06M 756
2017
Q4
$3.06M Sell
110,535
-10,093
-8% -$290K 0.02% 335
2017
Q3
$3.56M Sell
120,628
-10,348
-8% -$298K 0.02% 330
2017
Q2
$3.6M Sell
130,976
-10,539
-7% -$296K 0.02% 322
2017
Q1
$3.98M Sell
141,515
-29,861
-17% -$826K 0.02% 329
2016
Q4
$4.59M Sell
171,376
-2,776
-2% -$75.4K 0.02% 308
2016
Q3
$4.7M Sell
174,152
-10,332
-6% -$250K 0.02% 296
2016
Q2
$4.2M Buy
184,484
+4,858
+3% +$108K 0.02% 294
2016
Q1
$3.9M Buy
+179,626
New +$3.38M 0.03% 256

Other funds holding EVA

VanEck Associates's EVA Position: Q4 2023 in Review

VanEck Associates sold out of Enviva Inc. (EVA) in Q4 2023, closing a stake of 550 shares — an estimated $4K sold.

VanEck Associates first reported a position in EVA in Q1 2016 and held it in 17 quarters. The position peaked at $4.7M in Q3 2016. 117 funds tracked by Wall St. Rank hold EVA as of Q4 2023.

  • VanEck Associates reported no remaining Enviva Inc. position as of Q4 2023 after selling out during the quarter.
  • VanEck Associates sold 550 Enviva Inc. shares in Q4 2023, an estimated $4K.
  • VanEck Associates first reported a position in Enviva Inc. in Q1 2016 and held it in 17 quarters.
  • VanEck Associates's Enviva Inc. position peaked at $4.7M in Q3 2016.
  • 117 funds tracked by Wall St. Rank held Enviva Inc. as of Q4 2023.

Based on VanEck Associates's 13F filing for Q4 2023, filed 5 Feb 2024.